Excessive lysosomal ion-trapping of hydroxychloroquine and azithromycin

{ 'indexed': {'date-parts': [[2024, 4, 30]], 'date-time': '2024-04-30T06:31:01Z', 'timestamp': 1714458661901}, 'reference-count': 36, 'publisher': 'Elsevier BV', 'issue': '6', 'license': [ { 'start': { 'date-parts': [[2020, 6, 1]], 'date-time': '2020-06-01T00:00:00Z', 'timestamp': 1590969600000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}], 'content-domain': { 'domain': [ 'clinicalkey.jp', 'clinicalkey.com', 'clinicalkey.es', 'clinicalkey.com.au', 'clinicalkey.fr', 'elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2020, 6]]}, 'DOI': '10.1016/j.ijantimicag.2020.106007', 'type': 'journal-article', 'created': {'date-parts': [[2020, 5, 7]], 'date-time': '2020-05-07T08:45:30Z', 'timestamp': 1588841130000}, 'page': '106007', 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 37, 'title': 'Excessive lysosomal ion-trapping of hydroxychloroquine and azithromycin', 'prefix': '10.1016', 'volume': '55', 'author': [ { 'ORCID': 'http://orcid.org/0000-0003-4016-1370', 'authenticated-orcid': False, 'given': 'Hartmut', 'family': 'Derendorf', 'sequence': 'first', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': '10.1016/j.ijantimicag.2020.106007_bib0001', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ijantimicag.2020.105949', 'article-title': 'Hydroxychloroquine and azithromycin as a treatment of COVID-19: results ' 'of an open-label non-randomized clinical trial', 'author': 'Gautret', 'year': '2020', 'journal-title': 'Int J Antimicrob Agents'}, { 'key': '10.1016/j.ijantimicag.2020.106007_bib0002', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.tmaid.2020.101663', 'article-title': 'Clinical and microbiological effect of a combination of ' 'hydroxychloroquine and azithromycin in 80 COVID-19 patients with at ' 'least a six-day follow up: A pilot observational study', 'author': 'Gautret', 'year': '2020', 'journal-title': 'Travel Med Infect Dis'}, { 'key': '10.1016/j.ijantimicag.2020.106007_bib0003', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.medmal.2020.03.006', 'article-title': 'No evidence of rapid antiviral clearance or clinical benefit with the ' 'combination of hydroxychloroquine and azithromycin in patients with ' 'severe COVID-19 infection', 'author': 'Molina', 'year': '2020', 'journal-title': 'Med Mal Infect'}, { 'key': '10.1016/j.ijantimicag.2020.106007_bib0004', 'doi-asserted-by': 'crossref', 'DOI': '10.1503/cmaj.200528', 'article-title': 'Safety considerations with chloroquine, hydroxychloroquine and ' 'azithromycin in the management of SARS-CoV-2 infection', 'author': 'Juurlink', 'year': '2020', 'journal-title': 'CMAJ'}, { 'issue': '6', 'key': '10.1016/j.ijantimicag.2020.106007_bib0005', 'doi-asserted-by': 'crossref', 'first-page': '2540', 'DOI': '10.1128/AAC.01723-09', 'article-title': 'Cellular pharmacokinetics of the novel biaryloxazolidinone radezolid in ' 'phagocytic cells: studies with macrophages and polymorphonuclear ' 'neutrophils', 'volume': '54', 'author': 'Lemaire', 'year': '2010', 'journal-title': 'Antimicrob Agents Chemother'}, { 'key': '10.1016/j.ijantimicag.2020.106007_bib0006', 'doi-asserted-by': 'crossref', 'first-page': '963', 'DOI': '10.1016/j.toxrep.2014.10.019', 'article-title': 'Chloroquine and hydroxychloroquine binding to melanin: Some possible ' 'consequences for pathologies', 'volume': '1', 'author': 'Schroeder', 'year': '2014', 'journal-title': 'Toxicol Rep'}, { 'issue': '4', 'key': '10.1016/j.ijantimicag.2020.106007_bib0007', 'doi-asserted-by': 'crossref', 'first-page': '897', 'DOI': '10.1124/dmd.112.050054', 'article-title': 'Lysosomal sequestration (trapping) of lipophilic amine (cationic ' 'amphiphilic) drugs in immortalized human hepatocytes (Fa2N-4 cells)', 'volume': '41', 'author': 'Kazmi', 'year': '2013', 'journal-title': 'Drug Metab Dispos'}, { 'issue': '6', 'key': '10.1016/j.ijantimicag.2020.106007_bib0008', 'doi-asserted-by': 'crossref', 'first-page': '513', 'DOI': '10.1002/bod.2510090602', 'article-title': 'The potential role of lysosomes in tissue distribution of weak bases', 'volume': '9', 'author': 'MacIntyre', 'year': '1988', 'journal-title': 'Biopharm Drug Dispos'}, { 'issue': '3', 'key': '10.1016/j.ijantimicag.2020.106007_bib0009', 'doi-asserted-by': 'crossref', 'first-page': '303', 'DOI': '10.1111/j.1365-2125.1988.tb05281.x', 'article-title': 'A dose-ranging study of the pharmacokinetics of hydroxy-chloroquine ' 'following intravenous administration to healthy volunteers', 'volume': '26', 'author': 'Tett', 'year': '1988', 'journal-title': 'Br J Clin Pharmacol'}, { 'issue': '5-6', 'key': '10.1016/j.ijantimicag.2020.106007_bib0010', 'first-page': '211', 'article-title': 'Accumulation, release and subcellular localization of azithromycin in ' 'phagocytic and non-phagocytic cells in culture', 'volume': '16', 'author': 'Carlier', 'year': '1994', 'journal-title': 'Int J Tissue React'}, { 'issue': '1', 'key': '10.1016/j.ijantimicag.2020.106007_bib0011', 'doi-asserted-by': 'crossref', 'first-page': '86', 'DOI': '10.1006/excr.2002.5613', 'article-title': 'Azithromycin, a lysosomotropic antibiotic, has distinct effects on ' 'fluid-phase and receptor-mediated endocytosis, but does not impair ' 'phagocytosis in J774 macrophages', 'volume': '281', 'author': 'Tyteca', 'year': '2002', 'journal-title': 'Exp Cell Res'}, { 'issue': '7', 'key': '10.1016/j.ijantimicag.2020.106007_bib0012', 'doi-asserted-by': 'crossref', 'first-page': '466', 'DOI': '10.1078/0171-9335-00180', 'article-title': 'Azithromycin, a lysosomotropic antibiotic, impairs fluid-phase ' 'pinocytosis in cultured fibroblasts', 'volume': '80', 'author': 'Tyteca', 'year': '2001', 'journal-title': 'Eur J Cell Biol'}, { 'issue': '1-2', 'key': '10.1016/j.ijantimicag.2020.106007_bib0013', 'doi-asserted-by': 'crossref', 'first-page': '203', 'DOI': '10.1016/S0014-2999(96)00552-3', 'article-title': 'Interaction of the macrolide azithromycin with phospholipids. I. ' 'Inhibition of lysosomal phospholipase A1 activity', 'volume': '314', 'author': 'Van Bambeke', 'year': '1996', 'journal-title': 'Eur J Pharmacol'}, { 'issue': '11', 'key': '10.1016/j.ijantimicag.2020.106007_bib0014', 'doi-asserted-by': 'crossref', 'first-page': '6675', 'DOI': '10.1128/AAC.02904-14', 'article-title': 'Development of a population pharmacokinetic model characterizing the ' 'tissue distribution of azithromycin in healthy subjects', 'volume': '58', 'author': 'Zheng', 'year': '2014', 'journal-title': 'Antimicrob Agents Chemother'}, { 'issue': '4', 'key': '10.1016/j.ijantimicag.2020.106007_bib0015', 'first-page': '481', 'article-title': 'Gentamicin-induced lysosomal phospholipidosis in cultured rat ' 'fibroblasts. Quantitative ultrastructural and biochemical study', 'volume': '40', 'author': 'Aubert-Tulkens', 'year': '1979', 'journal-title': 'Lab Invest'}, { 'issue': '4', 'key': '10.1016/j.ijantimicag.2020.106007_bib0016', 'doi-asserted-by': 'crossref', 'first-page': '261', 'DOI': '10.1016/S108495210200054X', 'article-title': 'Introduction: lysosome-related organelles', 'volume': '13', 'author': 'Cutler', 'year': '2002', 'journal-title': 'Semin Cell Dev Biol'}, { 'issue': '3', 'key': '10.1016/j.ijantimicag.2020.106007_bib0017', 'doi-asserted-by': 'crossref', 'first-page': '665', 'DOI': '10.1083/jcb.68.3.665', 'article-title': 'Membrane flow during pinocytosis. A stereologic analysis', 'volume': '68', 'author': 'Steinman', 'year': '1976', 'journal-title': 'J Cell Biol'}, { 'key': '10.1016/j.ijantimicag.2020.106007_bib0018', 'unstructured': 'Pfizer. Zithromax product information. 2019; Available ' 'from:https://labeling.pfizer.com/ShowLabeling.aspx?id=511.'}, { 'issue': '5', 'key': '10.1016/j.ijantimicag.2020.106007_bib0019', 'doi-asserted-by': 'crossref', 'first-page': '431', 'DOI': '10.1016/j.ijantimicag.2010.01.023', 'article-title': 'Class-dependent relevance of tissue distribution in the interpretation ' 'of anti-infective pharmacokinetic/pharmacodynamic indices', 'volume': '35', 'author': 'Barbour', 'year': '2010', 'journal-title': 'Int J Antimicrob Agents'}, { 'issue': '3', 'key': '10.1016/j.ijantimicag.2020.106007_bib0020', 'doi-asserted-by': 'crossref', 'first-page': '196', 'DOI': '10.1002/jps.2600770303', 'article-title': 'role of lysosomes in hepatic accumulation of chloroquine', 'volume': '77', 'author': 'MacIntyre', 'year': '1988', 'journal-title': 'J Pharm Sci'}, { 'issue': '2 Pt 1', 'key': '10.1016/j.ijantimicag.2020.106007_bib0021', 'doi-asserted-by': 'crossref', 'first-page': '430', 'DOI': '10.1083/jcb.63.2.430', 'article-title': 'Protein degradation in cultured cells. II. The uptake of chloroquine by ' 'rat fibroblasts and the inhibition of cellular protein degradation and ' 'cathepsin B1', 'volume': '63', 'author': 'Wibo', 'year': '1974', 'journal-title': 'J Cell Biol'}, { 'issue': '3', 'key': '10.1016/j.ijantimicag.2020.106007_bib0022', 'doi-asserted-by': 'crossref', 'first-page': '665', 'DOI': '10.1083/jcb.90.3.665', 'article-title': 'Effect of weak bases on the intralysosomal pH in mouse peritoneal ' 'macrophages', 'volume': '90', 'author': 'Poole', 'year': '1981', 'journal-title': 'J Cell Biol'}, { 'issue': '3', 'key': '10.1016/j.ijantimicag.2020.106007_bib0023', 'doi-asserted-by': 'crossref', 'first-page': '407', 'DOI': '10.4269/ajtmh.2006.74.407', 'article-title': 'Lack of a pharmacokinetic interaction between azithromycin and ' 'chloroquine', 'volume': '74', 'author': 'Cook', 'year': '2006', 'journal-title': 'Am J Trop Med Hyg'}, { 'issue': '8', 'key': '10.1016/j.ijantimicag.2020.106007_bib0024', 'doi-asserted-by': 'crossref', 'first-page': '2518', 'DOI': '10.1128/AAC.46.8.2518-2524.2002', 'article-title': 'Assessment of azithromycin in combination with other antimalarial drugs ' 'against Plasmodium falciparum in vitro', 'volume': '46', 'author': 'Ohrt', 'year': '2002', 'journal-title': 'Antimicrob Agents Chemother'}, { 'issue': '4', 'key': '10.1016/j.ijantimicag.2020.106007_bib0025', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ijantimicag.2020.105932', 'article-title': 'Chloroquine and hydroxychloroquine as available weapons to fight ' 'COVID-19', 'volume': '55', 'author': 'Colson', 'year': '2020', 'journal-title': 'Int J Antimicrob Agents'}, { 'issue': '3', 'key': '10.1016/j.ijantimicag.2020.106007_bib0026', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ijantimicag.2020.105923', 'article-title': 'Chloroquine for the 2019 novel coronavirus SARS-CoV-2', 'volume': '55', 'author': 'Colson', 'year': '2020', 'journal-title': 'Int J Antimicrob Agents'}, { 'issue': '4', 'key': '10.1016/j.ijantimicag.2020.106007_bib0027', 'doi-asserted-by': 'crossref', 'first-page': '297', 'DOI': '10.1016/j.ijantimicag.2007.05.015', 'article-title': 'Recycling of chloroquine and its hydroxyl analogue to face bacterial, ' 'fungal and viral infections in the 21st century', 'volume': '30', 'author': 'Rolain', 'year': '2007', 'journal-title': 'Int J Antimicrob Agents'}, { 'key': '10.1016/j.ijantimicag.2020.106007_bib0028', 'doi-asserted-by': 'crossref', 'unstructured': 'Devaux CA, Rolain JM, Colson P, Raoult D. New insights on the antiviral ' 'effects of chloroquine against coronavirus: what to expect for ' 'COVID-19?Int J Antimicrob Agents2020:105938.', 'DOI': '10.1016/j.ijantimicag.2020.105938'}, { 'issue': '11', 'key': '10.1016/j.ijantimicag.2020.106007_bib0029', 'doi-asserted-by': 'crossref', 'first-page': '5642', 'DOI': '10.1128/JVI.78.11.5642-5650.2004', 'article-title': 'pH-dependent entry of severe acute respiratory syndrome coronavirus is ' 'mediated by the spike glycoprotein and enhanced by dendritic cell ' 'transfer through DC-SIGN', 'volume': '78', 'author': 'Yang', 'year': '2004', 'journal-title': 'J Virol'}, { 'issue': '2', 'key': '10.1016/j.ijantimicag.2020.106007_bib0030', 'doi-asserted-by': 'crossref', 'first-page': '265', 'DOI': '10.1016/j.virol.2011.02.020', 'article-title': 'Different host cell proteases activate the SARS-coronavirus ' 'spike-protein for cell-cell and virus-cell fusion', 'volume': '413', 'author': 'Simmons', 'year': '2011', 'journal-title': 'Virology'}, { 'issue': '3', 'key': '10.1016/j.ijantimicag.2020.106007_bib0031', 'doi-asserted-by': 'crossref', 'first-page': 'e91293', 'DOI': '10.1371/journal.pone.0091293', 'article-title': 'Efficacy of combination therapy with oseltamivir phosphate and ' 'azithromycin for influenza: a multicenter, open-label, randomized study', 'volume': '9', 'author': 'Kakeya', 'year': '2014', 'journal-title': 'PLoS One'}, { 'key': '10.1016/j.ijantimicag.2020.106007_bib0032', 'doi-asserted-by': 'crossref', 'DOI': '10.1155/2012/649570', 'article-title': 'Macrolide therapy in respiratory viral infections', 'volume': '2012', 'author': 'Min', 'year': '2012', 'journal-title': 'Mediators Inflamm'}, { 'key': '10.1016/j.ijantimicag.2020.106007_bib0033', 'article-title': 'PLAQUENIL® hydroxychloroquine sulfate tablets', 'year': '2015', 'journal-title': 'Product Information'}, { 'issue': '5', 'key': '10.1016/j.ijantimicag.2020.106007_bib0034', 'doi-asserted-by': 'crossref', 'first-page': '929', 'DOI': '10.4269/ajtmh.2007.77.929', 'article-title': 'Azithromycin/chloroquine combination does not increase cardiac ' 'instability despite an increase in monophasic action potential duration ' 'in the anesthetized guinea pig', 'volume': '77', 'author': 'Fossa', 'year': '2007', 'journal-title': 'Am J Trop Med Hyg'}, { 'key': '10.1016/j.ijantimicag.2020.106007_bib0035', 'doi-asserted-by': 'crossref', 'DOI': '10.1093/cid/ciaa237', 'article-title': 'In vitro antiviral activity and projection of optimized dosing design ' 'of hydroxychloroquine for the treatment of Severe Acute Respiratory ' 'Syndrome Coronavirus 2 (SARS-CoV-2)', 'author': 'Yao', 'year': '2020', 'journal-title': 'Clin Infect Dis'}, { 'key': '10.1016/j.ijantimicag.2020.106007_bib0036', 'series-title': "Goodman & Gilman's The Pharmacological Basis of Therapeutics", 'article-title': 'Design and optimization of dosage regimens: pharmacokinetic data', 'author': 'Thummel', 'year': '2006'}], 'container-title': 'International Journal of Antimicrobial Agents', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S0924857920301655?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S0924857920301655?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2020, 6, 23]], 'date-time': '2020-06-23T05:03:19Z', 'timestamp': 1592888599000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S0924857920301655'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2020, 6]]}, 'references-count': 36, 'journal-issue': {'issue': '6', 'published-print': {'date-parts': [[2020, 6]]}}, 'alternative-id': ['S0924857920301655'], 'URL': 'http://dx.doi.org/10.1016/j.ijantimicag.2020.106007', 'relation': {}, 'ISSN': ['0924-8579'], 'subject': [], 'container-title-short': 'International Journal of Antimicrobial Agents', 'published': {'date-parts': [[2020, 6]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Excessive lysosomal ion-trapping of hydroxychloroquine and azithromycin', 'name': 'articletitle', 'label': 'Article Title'}, { 'value': 'International Journal of Antimicrobial Agents', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.ijantimicag.2020.106007', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, { 'value': '© 2020 Elsevier B.V. and International Society of Chemotherapy. All rights ' 'reserved.', 'name': 'copyright', 'label': 'Copyright'}], 'article-number': '106007'}